EXHIBIT 31.1

        CERTIFICATION PURSUANT TO 18 U.S.C. 1350, AS ADOPTED PURSUANT TO
                 SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Rondald L.  Wheet, certify that:

     1.   I have  reviewed  this  quarterly  report  on  Form 10-Q of Revolution
          Medical  Corporation;

     2.   Based on  my  knowledge,  this  quarterly  report  does not contain an
          untrue  statement  of a material fact or omit to state a material fact
          necessary  to  make the statements made, in light of the circumstances
          under  which such statements were made, not misleading with respect to
          the  period  covered  by  this  quarterly  report;

     3.   Based on  my  knowledge,  the  financial  statements,  and  other
          financial  information  included  in  this  quarterly  report,  fairly
          present  in  all material respects the financial condition, results of
          operations  and  cash  flows  of  the  registrant  as of, and for, the
          periods  presented  in  this  quarterly  report;

     4.   I am responsible  for  establishing  and  maintaining  disclosure
          controls  and  procedures  (as  defined  in  Exchange Act Rules 13a-14
          and15d-14)  for  the  registrant  and  have:

          a.   designed  such  disclosure  controls  and  procedures  to  ensure
               that  material  information relating to the registrant, including
               its  consolidated  subsidiaries,  is  made  known to us by others
               within  those  entities,  particularly during the period in which
               this  quarterly  report  is  being  prepared;  b.  evaluated  the
               effectiveness  of  the  registrant's  disclosure  controls  and
               procedures  as  of a date within 90 days prior to the filing date
               of  this  quarterly  report  (the  "Evaluation  Date");  and  c.
               presented  in  this  quarterly  report  our conclusions about the
               effectiveness  of the disclosure controls and procedures based on
               our  evaluation  as  of  the  Evaluation  Date;

     5.   I have  disclosed,  based  on  our  most  recent  evaluation,  to  the
          registrant's auditors and the audit committee of registrant's board of
          directors  (or  persons  performing  the  equivalent  functions):

          a.   all significant  deficiencies  in  the  design  or  operation  of
               internal  controls  which could adversely affect the registrant's
               ability  to  record, process, summarize and report financial data
               and  have  identified  for the registrant's auditors any material
               weaknesses in internal controls; and
          b.   any fraud,  whether  or  not  material,  that involves management
               or  other  employees  who  have  a  significant  role  in  the
               registrant's  internal  controls;  and

     6.   I have  indicated  in  this  quarterly  report  whether  or  not there
          were significant changes in internal controls or in other factors that
          could significantly affect internal controls subsequent to the date of
          our  most  recent  evaluation,  including  any corrective actions with
          regard  to  significant  deficiencies  and  material  weaknesses.


Date:  August 14, 2008
                                        /s/ RONDALD L.  WHEET
                                        ------------------------------
                                        Rondald L.  Wheet
                                        CEO and  CFO